Plasminogen activator inhibitor type-1 (PAI-1) expression relates to the presence of myocardial inflammation in patients with nonischemic cardiomyopathy [2]

dc.contributor.authorEscher, F.
dc.contributor.authorAgirbasli, M.
dc.contributor.authorLassner, D.
dc.contributor.authorAleshcheva, G.
dc.contributor.authorSchultheiss, H. P.
dc.date.accessioned2025-05-10T19:27:39Z
dc.date.issued2019
dc.departmentİstanbul Medeniyet Üniversitesi
dc.descriptionCongress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology -- AUG 31-SEP 04, 2019 -- Paris, FRANCE
dc.description.abstract[No abstract available]
dc.description.sponsorshipEuropean Soc Cardiol
dc.identifier.endpage4049
dc.identifier.issn0195-668X
dc.identifier.issn1522-9645
dc.identifier.scopusqualityQ1
dc.identifier.startpage4049
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7013
dc.identifier.volume40
dc.identifier.wosWOS:000507313003711
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.ispartofEuropean Heart Journal
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titlePlasminogen activator inhibitor type-1 (PAI-1) expression relates to the presence of myocardial inflammation in patients with nonischemic cardiomyopathy [2]
dc.typeConference Object

Dosyalar